• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH TOTAL BILIRUBIN; DIAZO COLORIMETRY, BILIRUBIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH TOTAL BILIRUBIN; DIAZO COLORIMETRY, BILIRUBIN Back to Search Results
Catalog Number 06L45-22
Medical Device Problem Code High Test Results (2457)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/23/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Complete entry for section a1 - patient identifier: (b)(6), complete entry for section e1 - phone number: (b)(6).An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.
 
Event or Problem Description
The customer observed a falsely elevated total bilirubin on the architect c4000 processing module for one patient.The following results were provided (reference range, total bilirubin, 0.20 to 1.20 mg/dl): on (b)(6) 2024, sid (b)(6), initial total bilirubin result= 26.36 mg/dl; repeat result= 0.37 mg/dl.There was no impact to patient management reported.
 
Event or Problem Description
The customer observed a falsely elevated total bilirubin on the architect c4000 processing module for one patient.The following results were provided (reference range, total bilirubin, 0.20 to 1.20 mg/dl): (b)(6) 2024, sid (b)(6) , initial total bilirubin result= 26.36 mg/dl; repeat result= 0.37 mg/dl.There was no impact to patient management reported.
 
Additional Manufacturer Narrative
After further evaluation, the suspect medical device was changed from total bilirubin, list number 06l45-22, and manufacturing site abbott gmbh, wiesbaden to architect c4000, list number 02p24-01, and manufacturing site abbott laboratories, irving.Mdr number 3016438761-2025-00037 has been submitted and all further information will be documented under that mdr number.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TOTAL BILIRUBIN
Common Device Name
DIAZO COLORIMETRY, BILIRUBIN
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
Manufacturer (Section G)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM   65205
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key21114760
Report Number3002809144-2025-00005
Device Sequence Number7436330
Product Code CIG
UDI-Device Identifier00380740174965
UDI-Public(01)00380740174965(17)250731(10)65824UQ02
Combination Product (Y/N)N
Initial Reporter CountryBR
PMA/510(K) Number
K121985
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 01/17/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/31/2025
Device Catalogue Number06L45-22
Device Lot Number65824UQ02
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 12/23/2024
Supplement Date Received by Manufacturer01/13/2025
Initial Report FDA Received Date01/09/2025
Supplement Report FDA Received Date01/17/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured03/27/2024
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ARC C4 PROC MOD, 02P24-01, (B)(6); ARC C4 PROC MOD, 02P24-01, (B)(6)
Patient SexUnknown
-
-